2008 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1)
The summary for the 2008 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
2008 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1): -Purpose. This program is intended to fund scientists engaged in basic, clinical, or translational research on drug abuse and HIV/AIDS. The term avant-garde is used to describe highly innovative approaches that have the potential to produce an unusually high impact.The proposed research should reflect ideas substantially different from those already being pursued by the investigator or others. The research proposed must be in an area described in the Trans NIH Plan for HIV-Related Research (http://www.oar.nih.gov/updates/updates.htm) and be drug abuse relevant but need not be in a conventional biomedical or behavioral discipline. -Mechanism of Support. This FOA will utilize the NIH DP1 grant mechanism. -Funds Available and Anticipated Number of Awards. Approximately 2 to 3 awards of $500,000 in direct costs are anticipated for a total of up to $2 million per year for five years.
Federal Grant Title: | 2008 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-08-003 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse and Addiction Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Mar 26, 2008 |
Posted Date: | Nov 09, 2007 |
Creation Date: | Nov 09, 2007 |
Archive Date: | Apr 26, 2008 |
Total Program Funding: | $500,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments County governments For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Private institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...